Table 2. Therapeutic responses to eltrombopag.
a)Initial required doses to achieve target platelet count (≥50,000 cells/mL, N=13). b)Doses to maintain target platelet count (≥ 50,000 cells/mL, N=13).
Abbreviations: EOD, every other day; RFS, relapse-free survival.